Subscribe to Newsletter

Translational Science

Discovery & Development Drug Discovery

Can the FDA’s Shift Away from Animal Testing Deliver Real Reform?

| 7 min read

We speak with an advocate for alternative drug testing methods about the challenges that lie ahead.

Business & Regulation Standards & Regulation

FDA to Phase Out Animal Testing

| Rob Coker | 2 min read

FDA to phase out mandatory animal testing with human-relevant methods for drug development

Discovery & Development Drug Discovery

The Shingles Vaccine and Dementia

| Stephanie Vine | 2 min read

Studies have suggested that the RZV shingles vaccine can lower the risk of dementia; GSK is now investigating further.

Discovery & Development Drug Discovery

Hail to the Hardy Tardigrade

| Rob Coker | 2 min read

Why scientists are looking to the microscopic marvel of the tardigrade for new approaches to cancer treatment.

Manufacture Advanced Medicine

Meet the California Institute Pushing Stem Cell & Gene Therapy Research: Part 3

| Stephanie Vine | 6 min read

Welcome back to our interview series with Jon Thomas, President and CEO of the California Institute for Regenerative Medicine: CIRM.

Manufacture Advanced Medicine

Meet the California Institute Pushing Stem Cell and Gene Therapy Research: Part 1

| Stephanie Vine | 6 min read

Consider CIRM as a bank. We don’t conduct research ourselves: we fund it – and have become the largest dedicated funder of stem cell and gene therapy

Discovery & Development Translational Science

Of Mice and Monkeys

| Rob Coker | 3 min read

The contribution of macaques to advancing human understanding of flu-like viruses, including H5N1, cannot be overstated.

Business & Regulation Profession

Video Interview: Debra Weiss

Check out our video interview with Debra Weiss from the Bill & Melinda Gates Medical Research Institute.

Business & Regulation Trends & Forecasts

Dystopia or Utopia? Contribute to our Special Feature on the Future of Pharma

| Stephanie Vine | 4 min read

Contribute to our special feature celebrating the future of pharma.

Discovery & Development Formulation

MR Control

| Asma Patel, John McDermott | 4 min read

Developing modified release formulations can be complex – but a translational pharmaceutics approach can smooth the path


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register